BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38716832)

  • 21. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model.
    Wang M; Liu M; Sun J; Jia L; Ma S; Gao J; Xu Y; Zhang H; Tsang SY; Li X
    Reprod Biol; 2017 Dec; 17(4):295-304. PubMed ID: 29089199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
    Chen W; Liao B; Yun C; Zhao M; Pang Y
    J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Let-7e modulates the proliferation and the autophagy of human granulosa cells by suppressing p21 signaling pathway in polycystic ovary syndrome without hyperandrogenism.
    Li Y; Liu YD; Zhou XY; Zhang J; Wu XM; Yang YZ; Chen YX; Zhang XF; Li X; Ma LZ; Wang Z; Chen SL
    Mol Cell Endocrinol; 2021 Sep; 535():111392. PubMed ID: 34246727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
    Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development.
    Liao B; Qi X; Yun C; Qiao J; Pang Y
    Front Endocrinol (Lausanne); 2022; 13():815968. PubMed ID: 35237237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular fluid steroid and epidermal growth factor content, and in vitro estrogen release by granulosa-luteal cells from patients with polycystic ovaries in an IVF/ET program.
    Volpe A; Coukos G; D'Ambrogio G; Artini PG; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42(3):195-9. PubMed ID: 1773873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway.
    Qu F; Wang FF; Lu XE; Dong MY; Sheng JZ; Lv PP; Ding GL; Shi BW; Zhang D; Huang HF
    Hum Reprod; 2010 Jun; 25(6):1441-50. PubMed ID: 20378617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth differentiation factor-11 downregulates steroidogenic acute regulatory protein expression through ALK5-mediated SMAD3 signaling pathway in human granulosa-lutein cells.
    Jia Q; Liu B; Dang X; Guo Y; Han X; Song T; Cheng JC; Fang L
    Reprod Biol Endocrinol; 2022 Feb; 20(1):34. PubMed ID: 35183204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated SAA1 promotes the development of insulin resistance in ovarian granulosa cells in polycystic ovary syndrome.
    Zhu Q; Yao Y; Xu L; Wu H; Wang W; He Y; Wang Y; Lu Y; Qi J; Ding Y; Li X; Huang J; Zhao H; Du Y; Sun K; Sun Y
    Reprod Biol Endocrinol; 2022 Jan; 20(1):4. PubMed ID: 34980155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
    Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
    Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YKL-40 Knockdown Decreases Oxidative Stress Damage in Ovarian Granulosa Cells.
    Tang T; Gao J; Pan X; Tang Q; Long H; Liu Z
    Genet Test Mol Biomarkers; 2024 May; 28(5):199-206. PubMed ID: 38634621
    [No Abstract]   [Full Text] [Related]  

  • 36. Intra-ovarian inflammatory states and their associations with embryo quality in normal-BMI PCOS patients undergoing IVF treatment.
    Shang J; Wang S; Wang A; Li F; Zhang J; Wang J; Lv R; Chen H; Mu X; Zhang K; Bai X; Tian Y
    Reprod Biol Endocrinol; 2024 Jan; 22(1):11. PubMed ID: 38212789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between abnormal energy metabolism of ovarian granulosa cells and in vitro fertilization-embryo transfer outcomes in patients with polycystic ovary syndrome and obesity.
    Zhao YK; Gao YN; Wang LC; Wang J; Wang GJ; Wu HL
    J Ovarian Res; 2023 Jul; 16(1):145. PubMed ID: 37480140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11 beta-hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries.
    Owen EJ; Holownia P; Conway GS; Jacobs HS; Honour JW
    Fertil Steril; 1992 Oct; 58(4):713-8. PubMed ID: 1426315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.